In a recent CMN Live session, we spoke with Eligo Bioscience CEO Xavier Duportet about the human microbiome, its role in health and disease, and how...
Some of the best links we picked up around the internet
Paris-headquartered Eligo Bioscience has achieved a major breakthrough in microbiome editing. In an article published moments ago in Nature, the...
Paris, FRANCE – December 5th 2023 – Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the expression of...
Eligo Bioscience announced today the issuance by the US Patent and Trademark Office of a landmark CRISPR patent that broadly covers any therapeutic...
